Clinical Trial Update: Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating dendritic cell-based vaccines loaded with allogeneic prostate cell lines in combination with androgen ablation for prostate cancer has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms Prostate
• Prostate Cancer
• Prostatic Cancer
• Prostatic Neoplasms

Drugs mentioned

• Dendritic cell-based vaccine (allogeneic prostate cell line–loaded)
• androgen ablation

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Cancer of Prostate, Cancer of the Prostate | Phase 2 | Status: COMPLETED | Results posted: 2020-05-07